NCT02620657View on ClinicalTrials.gov

Evaluate EGFR Mutation Status and Impact Factors in North China

CompletedOBSERVATIONAL
Enrollment

2,809

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

November 8, 2017

Study Completion Date

November 8, 2017

Conditions
Non-Small Cell Lung Cancer
Interventions
OTHER

Non interventional study

Non interventional study

All Listed Sponsors
lead

ying cheng

OTHER

NCT02620657 - Evaluate EGFR Mutation Status and Impact Factors in North China | Biotech Hunter | Biotech Hunter